Cargando…

Qualification of Necroptosis-Related lncRNA to Forecast the Treatment Outcome, Immune Response, and Therapeutic Effect of Kidney Renal Clear Cell Carcinoma

BACKGROUND: Kidney renal clear cell carcinoma (KIRC) is considered as a highly immune infiltrative tumor. Necroptosis is an inflammatory programmed cell death associated with a wide range of diseases. Long noncoding RNAs (lncRNAs) play important roles in gene regulation and immune function. lncRNA a...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Yisheng, Tian, Yiqun, Ren, Xiang, Wang, Jing, Li, Xing, Zeng, Xiaoyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550517/
https://www.ncbi.nlm.nih.gov/pubmed/36226251
http://dx.doi.org/10.1155/2022/3283343
_version_ 1784805905319067648
author Yin, Yisheng
Tian, Yiqun
Ren, Xiang
Wang, Jing
Li, Xing
Zeng, Xiaoyong
author_facet Yin, Yisheng
Tian, Yiqun
Ren, Xiang
Wang, Jing
Li, Xing
Zeng, Xiaoyong
author_sort Yin, Yisheng
collection PubMed
description BACKGROUND: Kidney renal clear cell carcinoma (KIRC) is considered as a highly immune infiltrative tumor. Necroptosis is an inflammatory programmed cell death associated with a wide range of diseases. Long noncoding RNAs (lncRNAs) play important roles in gene regulation and immune function. lncRNA associated with necroptosis could systematically explore the prognostic value, regulate tumor microenvironment (TME), etc. METHOD: The patients' data was collected from TCGA datasets. We used the univariate Cox regression (UCR) to select prediction lncRNAs that are related to necroptosis. Meanwhile, risk models were constructed using LASSO Cox regression (LCR). Kaplan–Meier (KM) analysis, accompanied with receiver operating characteristic (ROC) curves, was performed to assess the independent risk factors of different clinical characteristics. The evaluated factors are age, gender, disease staging, grade, and their related risk score. Databases such as Gene Ontology (GO), Kyoto encyclopedia of genes and genomes (KEGG), and Gene set enrichment analysis (GSEA) were used to search the probable biological characteristics that could influence the risk groups, containing signaling pathway and immue-related pathways. The single-sample gene set enrichment analysis (ssGSEA) was chosen to perform gene set variation analysis (GSVA), and the GSEABase package was selected to detect the immune and inflammatory infiltration profiles. The TIDE and IC(50) evaluation were used to estimate the effectiveness of clinical treatment on KIRC. RESULTS: Based on the above analysis, we have got a conclusion that patients who show high risk had higher immune infiltration, immune checkpoint expression, and poorer prognosis. We identified 19 novel prognostic necroptosis-related lncRNAs, which could offer opinions for a deeper study of KIRC. CONCLUSION: The risk model we constructed makes it possible to predict the prognosis of KIRC patients and offers directions for further research on the prognostication and treatment strategies for KIRC.
format Online
Article
Text
id pubmed-9550517
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-95505172022-10-11 Qualification of Necroptosis-Related lncRNA to Forecast the Treatment Outcome, Immune Response, and Therapeutic Effect of Kidney Renal Clear Cell Carcinoma Yin, Yisheng Tian, Yiqun Ren, Xiang Wang, Jing Li, Xing Zeng, Xiaoyong J Oncol Research Article BACKGROUND: Kidney renal clear cell carcinoma (KIRC) is considered as a highly immune infiltrative tumor. Necroptosis is an inflammatory programmed cell death associated with a wide range of diseases. Long noncoding RNAs (lncRNAs) play important roles in gene regulation and immune function. lncRNA associated with necroptosis could systematically explore the prognostic value, regulate tumor microenvironment (TME), etc. METHOD: The patients' data was collected from TCGA datasets. We used the univariate Cox regression (UCR) to select prediction lncRNAs that are related to necroptosis. Meanwhile, risk models were constructed using LASSO Cox regression (LCR). Kaplan–Meier (KM) analysis, accompanied with receiver operating characteristic (ROC) curves, was performed to assess the independent risk factors of different clinical characteristics. The evaluated factors are age, gender, disease staging, grade, and their related risk score. Databases such as Gene Ontology (GO), Kyoto encyclopedia of genes and genomes (KEGG), and Gene set enrichment analysis (GSEA) were used to search the probable biological characteristics that could influence the risk groups, containing signaling pathway and immue-related pathways. The single-sample gene set enrichment analysis (ssGSEA) was chosen to perform gene set variation analysis (GSVA), and the GSEABase package was selected to detect the immune and inflammatory infiltration profiles. The TIDE and IC(50) evaluation were used to estimate the effectiveness of clinical treatment on KIRC. RESULTS: Based on the above analysis, we have got a conclusion that patients who show high risk had higher immune infiltration, immune checkpoint expression, and poorer prognosis. We identified 19 novel prognostic necroptosis-related lncRNAs, which could offer opinions for a deeper study of KIRC. CONCLUSION: The risk model we constructed makes it possible to predict the prognosis of KIRC patients and offers directions for further research on the prognostication and treatment strategies for KIRC. Hindawi 2022-10-03 /pmc/articles/PMC9550517/ /pubmed/36226251 http://dx.doi.org/10.1155/2022/3283343 Text en Copyright © 2022 Yisheng Yin et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Yin, Yisheng
Tian, Yiqun
Ren, Xiang
Wang, Jing
Li, Xing
Zeng, Xiaoyong
Qualification of Necroptosis-Related lncRNA to Forecast the Treatment Outcome, Immune Response, and Therapeutic Effect of Kidney Renal Clear Cell Carcinoma
title Qualification of Necroptosis-Related lncRNA to Forecast the Treatment Outcome, Immune Response, and Therapeutic Effect of Kidney Renal Clear Cell Carcinoma
title_full Qualification of Necroptosis-Related lncRNA to Forecast the Treatment Outcome, Immune Response, and Therapeutic Effect of Kidney Renal Clear Cell Carcinoma
title_fullStr Qualification of Necroptosis-Related lncRNA to Forecast the Treatment Outcome, Immune Response, and Therapeutic Effect of Kidney Renal Clear Cell Carcinoma
title_full_unstemmed Qualification of Necroptosis-Related lncRNA to Forecast the Treatment Outcome, Immune Response, and Therapeutic Effect of Kidney Renal Clear Cell Carcinoma
title_short Qualification of Necroptosis-Related lncRNA to Forecast the Treatment Outcome, Immune Response, and Therapeutic Effect of Kidney Renal Clear Cell Carcinoma
title_sort qualification of necroptosis-related lncrna to forecast the treatment outcome, immune response, and therapeutic effect of kidney renal clear cell carcinoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550517/
https://www.ncbi.nlm.nih.gov/pubmed/36226251
http://dx.doi.org/10.1155/2022/3283343
work_keys_str_mv AT yinyisheng qualificationofnecroptosisrelatedlncrnatoforecastthetreatmentoutcomeimmuneresponseandtherapeuticeffectofkidneyrenalclearcellcarcinoma
AT tianyiqun qualificationofnecroptosisrelatedlncrnatoforecastthetreatmentoutcomeimmuneresponseandtherapeuticeffectofkidneyrenalclearcellcarcinoma
AT renxiang qualificationofnecroptosisrelatedlncrnatoforecastthetreatmentoutcomeimmuneresponseandtherapeuticeffectofkidneyrenalclearcellcarcinoma
AT wangjing qualificationofnecroptosisrelatedlncrnatoforecastthetreatmentoutcomeimmuneresponseandtherapeuticeffectofkidneyrenalclearcellcarcinoma
AT lixing qualificationofnecroptosisrelatedlncrnatoforecastthetreatmentoutcomeimmuneresponseandtherapeuticeffectofkidneyrenalclearcellcarcinoma
AT zengxiaoyong qualificationofnecroptosisrelatedlncrnatoforecastthetreatmentoutcomeimmuneresponseandtherapeuticeffectofkidneyrenalclearcellcarcinoma